Top Markets
Coin of the day
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Rang in Aktien #24496
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Aktienkurs
$52.60
Zuletzt synchronisiert: 2024-01-15
Marktkapitalisierung
$59.92M
Veränderung (1 Tag)
6.81%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Dechra Pharmaceuticals PLC (DPH)

Kategorie

Preis DPH mit Marktkapitalisierung von B
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
DPH
$52.60
Marktkapitalisierung von Dechra Pharmaceuticals PLC(DPH)
Marktkapitalisierung: $59.92M
Mit Stand August 2026 hat Dechra Pharmaceuticals PLC eine Marktkapitalisierung von $59.92M. Das macht Dechra Pharmaceuticals PLC laut unseren Daten zum 24496th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Dechra Pharmaceuticals PLC von 2000 bis 2026
DPH im Vergleich zu den Top 5 der beliebtesten stocks
Preis für DPH Vermögenswert B Marktkapitalisierung von B Ergebnisse
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$4,574,232 $59.92M
$5.210T +8,695,377.77%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,978,981 $59.92M
$4.532T +7,563,823.00%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,647,664 $59.92M
$4.155T +6,934,000.04%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,147,707 $59.92M
$3.585T +5,983,596.10%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$2,446,049 $59.92M
$2.786T +4,649,765.81%